EUVIMEDEUVIMED entdecken
Open Access

Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered

Phillip Grovenstein iD, Noopur Bhatnagar iD, Ki-Hye Kim, Surya Sekhar Pal, Chau Thuy Tien Le iD, Jannatul Ruhan Raha, Rong Liu, Chong Hyun Shin iD, Bo Ryoung Park, Lanying Du iD, Jeeva Subbiah iD, Bao-Zhong Wang und 1 weitere

The Journal of Immunology · 01.01.2025 · 214 (1) · 104-114

DOI: 10.1093/jimmun/vkae013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 31.01.2025. Verfasst von Phillip Grovenstein und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States. Hauptthemen laut MEDLINE: Influenza Vaccines, Nanoparticles, Orthomyxoviridae Infections, Viral Matrix Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH, NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current influenza vaccines are not effective in conferring protection against antigenic variants and pandemics. To improve cross-protection of influenza vaccination, we developed a 5xM2e messenger RNA (mRNA) vaccine encoding the tandem repeat conserved ectodomain (M2e) of ion channel protein M2 derived from human, swine, and avian influenza A viruses. The lipid nanoparticle (LNP)–encapsulated 5xM2e mRNA vaccine was immunogenic, eliciting high levels of M2e-specific IgG antibodies, IFN-γ+ T cells, T follicular helper cells, germinal center phenotypic B cells, and plasma cells. The mice with 5xM2e mRNA vaccination were broadly protected against lethal infection regardless of hemagglutinin (H1, H3, H5) subtypes by preventing severe weight loss. Injection of 5xM2e mRNA LNP vaccine induced acute innate responses recruiting monocytes, macrophages, and diverse subsets of dendritic cells. A single dose of combined 5xM2e mRNA LNP and split vaccines resulted in significantly enhanced and sustainable IgG antibody responses to viral antigens and protection against homologous and heterologous viruses. This study provides a new strategy of combined mRNA and seasonal vaccination, significantly enhancing vaccine protective efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesNanoparticlesOrthomyxoviridae InfectionsViral Matrix ProteinsInfluenza A virusAnimalsMiceAntibodies, ViralVaccines, InactivatedRNA, MessengerHumansFemaleVaccinationImmunoglobulin GLipidsCross ProtectionmRNA VaccinesMice, Inbred BALB CMice, Inbred C57BLNanovaccinesViroporin ProteinsLiposomes

Stichwörter der Autor:innen

influenzamRNA vaccinemiceviral

Substanzen

Influenza VaccinesAntibodies, ViralLipid NanoparticlesVaccines, InactivatedRNA, MessengerViral Matrix ProteinsM2 protein, Influenza A virusImmunoglobulin GLipidsmRNA Vaccines

Autor:innen und Institutionen

  • Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States.

ORCID-Profile: Phillip Grovenstein, Noopur Bhatnagar, Chau Thuy Tien Le, Chong Hyun Shin, Lanying Du, Jeeva Subbiah

Förderung

  • NIAID NIH HHS
  • NIH
  • NIAID

Zitieren

APA

Grovenstein, P., Bhatnagar, N., Kim, K. H., Pal, S. S., Le, C. T. T., Raha, J. R., Liu, R., Shin, C. H., Park, B. R., Du, L., Subbiah, J., Wang, B. Z., & Kang, S. M. (2025). Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered. The Journal of Immunology, 214(1), 104-114. https://doi.org/10.1093/jimmun/vkae013

Vancouver

Grovenstein P, Bhatnagar N, Kim KH, Pal SS, Le CTT, Raha JR, et al. Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered. The Journal of Immunology. 2025;214(1):104-114. doi:10.1093/jimmun/vkae013

BibTeX
@article{Grovenstein2025,
  author = {Grovenstein, Phillip and Bhatnagar, Noopur and Kim, Ki-Hye and Pal, Surya Sekhar and Le, Chau Thuy Tien and Raha, Jannatul Ruhan and Liu, Rong and Shin, Chong Hyun and Park, Bo Ryoung and Du, Lanying and Subbiah, Jeeva and Wang, Bao-Zhong and Kang, Sang-Moo},
  title = {Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered},
  journal = {The Journal of Immunology},
  year = {2025},
  volume = {214},
  number = {1},
  pages = {104--114},
  doi = {10.1093/jimmun/vkae013}
}
Kostenlos starten →